Replies to post #377083 on Elite Pharmaceuticals Inc (ELTP)

[JamesF1]

Retail pharmacy, for the most part, does not have control over the price they sell prescription meds. They have to take what the insurance will pay. Uninsured patients are in the minority..

[WeeZuhl]

This could hurt Adderall long term as it could be shifting customers to other stimulants available today that feel that their perceived risk of drug being out of stock is mitigated.

My partner prescribes a lot more ADD drugs than me, so I asked her. She prescribes a goodly amount of Adderall IR and Adderall XR, and she said there have been a few minor inconveniences but no major problems acquiring it at our local pharmacies. If insurance isn't an issue, she prefers Vyvanse and would typically prescribe it over Adderall XR when first starting an ADD drug. She said it is common for her to change someone from Adderall to Vyvanse due to side effects or decreased effectiveness, but she hasn't had to do it because of the shortage. She said she has good luck using lower doses of Adderall IR to supplement Vyvanse, similar to how she would use it to supplement Adderall XR. She frequently does insurance prior approval requests for Vyvanse, but if insurance declines the brand name drug request, then she is more likely to prescribe Adderall XR. Without insurance, generic Adderall XR is about $30/month and brand name Vyvanse is over $300/month.

.